Clinical Trials List
2022-01-05 - 2029-11-11
Phase III
Recruiting9
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yueh-Lin Wu 無
- Chung-Te Liu Division of Nephrology
- 楊韻紅 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- I-jen Chiu Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- 高芷華 無
- Li-Yee Hong Division of Nephrology
- Mei-Yi Wu Division of Nephrology
- 林冠宏 無
- Chia-Te Liao Division of Nephrology
- I-WEN WU 無
- YUNG-HO HSU Division of Nephrology
- YUEH-HSUN LU 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kuan-Der Lee Division of Nephrology
- TUNG-MIN YU 無
- 林雁婷 無
- 蔡尚峰 無
- CHENG-HSU CHEN 無
- 徐佳鈿 無
- 鍾牧圻 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yen-Chung Lin Division of Nephrology
- Shu-Ching Yeh Division of Nephrology
- Li-Chun Hsieh Division of Radiology
- Te-Chao Fang Division of Nephrology
- 陳靜怡 Division of Nephrology
- I-WEN WU 無
- Hsi-Hsien Chen Division of Nephrology
- 鄭碩仁 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
685 participants
